Literature DB >> 15507602

A retroviral promoter and a cellular enhancer define a bipartite element which controls env ERVWE1 placental expression.

Sarah Prudhomme1, Guy Oriol, François Mallet.   

Abstract

The HERV-W family contains hundreds of loci diversely expressed in several physiological and pathological contexts. A unique locus termed ERVWE1 encodes an envelope glycoprotein (syncytin) involved in hominoid placental physiology. Here we show that syncytin expression is regulated by a bipartite element consisting of a cyclic AMP (cAMP)-inducible long terminal repeat (LTR) retroviral promoter adjacent to a cellular enhancer conferring a high level of expression and placental tropism. Deletion mutant analysis showed that the ERVWE1 5' LTR contains binding sites essential for basal placental activity in the region from positions +1 to +125. The region from positions +125 to +310 represents a cAMP-responsive core HERV-W promoter active in all cell types. Site-directed mutagenesis analysis highlighted the complexity of U3 regulation. ERVWE1 placenta-specific positive (e.g., T240) and negative (e.g., G71) regulatory sites were identified, as were essential sites required for basic activity (e.g., A247). The flanking sequences of the ERVWE1 provirus contain several putative regulatory elements. The upstream HERV-H and HERV-P LTRs were found to be inactive. Conversely, the 436-bp region located between the HERV-P LTR and ERVWE1 was shown to be an upstream regulatory element (URE) which is significantly active in placenta cells. This URE acts as a tissue-specific enhancer. Genetic and functional analyses of hominoid UREs revealed large differences between UREs of members of the Hominidae and the Hylobatidae. These data allowed the identification of a positive regulatory region from positions -436 to -128, a mammalian apparent LTR retrotransposon negative regulatory region from positions -128 to -67, and a trophoblast-specific enhancer (TSE) from positions -67 to -35. Putative AP-2, Sp-1, and GCMa binding sites are essential constituents of the 33-bp TSE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507602      PMCID: PMC525085          DOI: 10.1128/JVI.78.22.12157-12168.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Processed pseudogenes of human endogenous retroviruses generated by LINEs: their integration, stability, and distribution.

Authors:  Adam Pavlícek; Jan Paces; Daniel Elleder; Jirí Hejnar
Journal:  Genome Res       Date:  2002-03       Impact factor: 9.043

2.  GCMa regulates the syncytin-mediated trophoblastic fusion.

Authors:  Chenchou Yu; Kuofeng Shen; Meiyao Lin; Porchun Chen; Chenchen Lin; Geen-Dong Chang; Hungwen Chen
Journal:  J Biol Chem       Date:  2002-10-22       Impact factor: 5.157

3.  The Opitz syndrome gene Mid1 is transcribed from a human endogenous retroviral promoter.

Authors:  Josette-Renée Landry; Arefeh Rouhi; Patrik Medstrand; Dixie L Mager
Journal:  Mol Biol Evol       Date:  2002-11       Impact factor: 16.240

4.  A GCM motif protein is involved in placenta-specific expression of human aromatase gene.

Authors:  K Yamada; H Ogawa; S Honda; N Harada; T Okazaki
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

5.  PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation.

Authors:  A Tarrade; K Schoonjans; J Guibourdenche; J M Bidart; M Vidaud; J Auwerx; C Rochette-Egly; D Evain-Brion
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

6.  Syncytin, a novel human endogenous retroviral gene in human placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome.

Authors:  Ina Knerr; Ernst Beinder; Wolfgang Rascher
Journal:  Am J Obstet Gynecol       Date:  2002-02       Impact factor: 8.661

7.  AP-2 gamma and the homeodomain protein distal-less 3 are required for placental-specific expression of the murine 3 beta-hydroxysteroid dehydrogenase VI gene, Hsd3b6.

Authors:  Lihong Peng; Anita H Payne
Journal:  J Biol Chem       Date:  2001-12-31       Impact factor: 5.157

8.  Placenta-specific INSL4 expression is mediated by a human endogenous retrovirus element.

Authors:  Ivan Bièche; Anne Laurent; Ingrid Laurendeau; Laurent Duret; Yves Giovangrandi; Jean-Louis Frendo; Martine Olivi; Jean-Luc Fausser; Danièle Evain-Brion; Michel Vidaud
Journal:  Biol Reprod       Date:  2002-11-27       Impact factor: 4.285

9.  Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases.

Authors:  J B Johnston; C Silva; J Holden; K G Warren; A W Clark; C Power
Journal:  Ann Neurol       Date:  2001-10       Impact factor: 10.422

10.  Transcription of cholesterol side-chain cleavage cytochrome P450 in the placenta: activating protein-2 assumes the role of steroidogenic factor-1 by binding to an overlapping promoter element.

Authors:  Micha Ben-Zimra; Moriah Koler; Joseph Orly
Journal:  Mol Endocrinol       Date:  2002-08
View more
  34 in total

1.  Characterization of the intronic portion of cadherin superfamily members, common cancer orchestrators.

Authors:  Patrícia Oliveira; Remo Sanges; David Huntsman; Elia Stupka; Carla Oliveira
Journal:  Eur J Hum Genet       Date:  2012-02-08       Impact factor: 4.246

2.  Placenta-specific expression of the interleukin-2 (IL-2) receptor β subunit from an endogenous retroviral promoter.

Authors:  Carla J Cohen; Rita Rebollo; Sonja Babovic; Elizabeth L Dai; Wendy P Robinson; Dixie L Mager
Journal:  J Biol Chem       Date:  2011-08-24       Impact factor: 5.157

3.  Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders.

Authors:  Oliver Frank; Michelle Giehl; Chun Zheng; Rüdiger Hehlmann; Christine Leib-Mösch; Wolfgang Seifarth
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Comparative methylation of ERVWE1/syncytin-1 and other human endogenous retrovirus LTRs in placenta tissues.

Authors:  Juliette Gimenez; Cécile Montgiraud; Guy Oriol; Jean-Philippe Pichon; Karine Ruel; Vassilis Tsatsaris; Pascale Gerbaud; Jean-Louis Frendo; Danièle Evain-Brion; François Mallet
Journal:  DNA Res       Date:  2009-06-27       Impact factor: 4.458

Review 5.  The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation.

Authors:  Hervé Perron; Alois Lang
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

6.  Influenza A virus transactivates the mouse envelope gene encoding syncytin B and its regulator, glial cells missing 1.

Authors:  Linnéa Asp; Christoffer Nellåker; Håkan Karlsson
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

7.  Comprehensive analysis of human endogenous retrovirus group HERV-W locus transcription in multiple sclerosis brain lesions by high-throughput amplicon sequencing.

Authors:  Katja Schmitt; Christin Richter; Christina Backes; Eckart Meese; Klemens Ruprecht; Jens Mayer
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

8.  Activation of elements in HERV-W family by caffeine and aspirin.

Authors:  Chunlan Liu; Yatang Chen; Shan Li; Honglian Yu; Jie Zeng; Xiuling Wang; Fan Zhu
Journal:  Virus Genes       Date:  2013-06-28       Impact factor: 2.332

9.  Transcriptional derepression of the ERVWE1 locus following influenza A virus infection.

Authors:  Fang Li; Christoffer Nellåker; Sarven Sabunciyan; Robert H Yolken; Lorraine Jones-Brando; Anne-Sofie Johansson; Björn Owe-Larsson; Håkan Karlsson
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

10.  Genome-Wide Screening of Retroviral Envelope Genes in the Nine-Banded Armadillo (Dasypus novemcinctus, Xenarthra) Reveals an Unfixed Chimeric Endogenous Betaretrovirus Using the ASCT2 Receptor.

Authors:  Sébastien Malicorne; Cécile Vernochet; Guillaume Cornelis; Baptiste Mulot; Frédéric Delsuc; Odile Heidmann; Thierry Heidmann; Anne Dupressoir
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.